Reference
Trifiro G, et al. Long-term intravitreal ranibizumab as a potential additional risk factor for neurodegeneration in Parkinson's Disease: A case report. Frontiers in Pharmacology 9: No. 608, 8 Jun 2018. Available from: URL: http://doi.org/10.3389/fphar.2018.00608 - Italy
Rights and permissions
About this article
Cite this article
Ranibizumab. Reactions Weekly 1710, 275 (2018). https://doi.org/10.1007/s40278-018-48947-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-48947-9